Abstract
Pulmonary function tests are commonly used within research to characterize disease patterns of obstructive airway diseases, and to describe lung growth and development. 20 out of 52 European birth cohorts within the ENRIECOand GA2LEN-networks reported a total of 80 investigation time-points using pulmonary function assessments. Information on published results and guidelines used were complemented through publicly available data and peer reviewed journals. Only 4 cohorts used the same test for at least 3 time-points during their follow-up. The tests were used to classify airway obstruction, bronchodilator response and bronchial hyperresponsiveness. Related methods assessed airway inflammation non-invasively. International guidelines, used in clinical practice, (American Thoracic Society/ European Respiratory Society) should be considered and referred to whenever possible to improve comparability. A consensus on when and how pulmonary function tests are beneficial in population based research, assessing lung growth or asthma subtypes, is needed.
Keywords: Asthma, exhaled nitric oxide, guidelines, lung development, spirometry.
Current Respiratory Medicine Reviews
Title:Pulmonary Function Tests in European Birth Cohorts
Volume: 9 Issue: 1
Author(s): Linus Grabenhenrich, Cynthia Hohmann, Remy Slama, Joachim Heinrich, Magnus Wickman, Carel Thijs, Kai-Hakon Carlsen, Karin Lodrup Carlsen, Susanne Lau and Thomas Keil
Affiliation:
Keywords: Asthma, exhaled nitric oxide, guidelines, lung development, spirometry.
Abstract: Pulmonary function tests are commonly used within research to characterize disease patterns of obstructive airway diseases, and to describe lung growth and development. 20 out of 52 European birth cohorts within the ENRIECOand GA2LEN-networks reported a total of 80 investigation time-points using pulmonary function assessments. Information on published results and guidelines used were complemented through publicly available data and peer reviewed journals. Only 4 cohorts used the same test for at least 3 time-points during their follow-up. The tests were used to classify airway obstruction, bronchodilator response and bronchial hyperresponsiveness. Related methods assessed airway inflammation non-invasively. International guidelines, used in clinical practice, (American Thoracic Society/ European Respiratory Society) should be considered and referred to whenever possible to improve comparability. A consensus on when and how pulmonary function tests are beneficial in population based research, assessing lung growth or asthma subtypes, is needed.
Export Options
About this article
Cite this article as:
Grabenhenrich Linus, Hohmann Cynthia, Slama Remy, Heinrich Joachim, Wickman Magnus, Thijs Carel, Carlsen Kai-Hakon, Carlsen Karin Lodrup, Lau Susanne and Keil Thomas, Pulmonary Function Tests in European Birth Cohorts, Current Respiratory Medicine Reviews 2013; 9 (1) . https://dx.doi.org/10.2174/1573398X11309010002
DOI https://dx.doi.org/10.2174/1573398X11309010002 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Heme Oxygenase-1 and Carbon Monoxide: Emerging Therapeutic Targets in Inflammation and Allergy
Recent Patents on Inflammation & Allergy Drug Discovery Simultaneous Quantitative Determinations of Fluticasone Propionate and Salmeterol Xinafote in Diskus Inhalers
Drug Metabolism Letters Anti-inflammatory and Hypolipidemic Effect of Novel Conjugates with Trolox and Other Antioxidant Acids
Medicinal Chemistry Vaccines For Type 1 Diabetes: Prevention or Reversal?
Current Diabetes Reviews Cucurbitacins and the Immune System: Update in Research on Anti- inflammatory, Antioxidant, and Immunomodulatory Mechanisms
Current Medicinal Chemistry The Promise of Plant-Derived Substances as Inhibitors of Arginase
Mini-Reviews in Medicinal Chemistry Phenolic Compounds: the Role of Redox Regulation in Neurodegenerative Disease and Cancer
Mini-Reviews in Medicinal Chemistry Novel Carriers for Coenzyme Q10 Delivery
Current Drug Delivery Tuberculosis, an Old Disease Lacking New Therapeutic Drugs
Current Drug Therapy Editorial [Hot topic: Innate Immunity Molecules S100A8/A9 Involved in Stress Response and Cancer Biology (Guest Editors: Claus Kerkhoff and Saeid Ghavami)]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Association Study of IL-4 -590 C/T and DDX39B -22 G/C Polymorphisms with the Risk of Late-Onset Alzheimer’s Disease in Iranian Population
Current Aging Science S-Nitrosothiols as Nitric Oxide-Donors: Chemistry, Biology and Possible Future Therapeutic Applications
Current Medicinal Chemistry Therapeutic Progress and Knowledge Basis on the Natriuretic Peptide System in Heart Failure
Current Topics in Medicinal Chemistry The Safety of Bisphosphonate Use in Premenopausal Women on Corticosteroids
Current Drug Safety An Update on NLRP3 Inflammasome Activation by Engineered Nanomaterials
Current Bionanotechnology (Discontinued) Properties and Therapeutic Potential of Transient Receptor Potential Channels with Putative Roles in Adversity: Focus on TRPC5, TRPM2 and TRPA1
Current Drug Targets Matrix Metalloproteinases in Respiratory Diseases: From Pathogenesis to Potential Clinical Implications
Current Medicinal Chemistry The Basement Membrane Zone in Asthma
Current Respiratory Medicine Reviews Immunomodulatory and Anti-Inflammatory Activities of Statins
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial [Hot Topic:Therapeutic Potential of Peptide Motifs - Part V (Executive Guest Editor: Jean-Claude Herve)]
Current Pharmaceutical Design